Abstract
Complement factor I (CFI) mutations are implicated in the pathogenesis of atypical hemolytic uremic syndrome (aHUS). Nevertheless, there is evidence that CFI deficiency is a weak effector of aHUS. Bienaime et al. report that homozygous deletion of CFHR-1 in the RCA gene cluster of chromosome 1q is a major risk factor for poor outcome for patients with CFI mutations. The basic and clinical implications of the findings are further elaborated here. © 2010 International Society of Nephrology.
Cite
CITATION STYLE
Tsai, H. M. (2010). Excessive activation of the complement system in atypical hemolytic uremic syndrome: Is it ready for prime time. Kidney International. Nature Publishing Group. https://doi.org/10.1038/ki.2009.467
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.